Stage III Hypopharyngeal Carcinoma AJCC v8

16 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)	National Cancer Institute (NCI)	2022-07-06
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT04533750)	National Cancer Institute (NCI)	2021-12-20
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840)	M.D. Anderson Cancer Center	2020-10-19
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin (NCT04541355)	Hyunseok Kang, MD	2020-10-14
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT04162873)	University of Utah	2019-11-27
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT03258554)	National Cancer Institute (NCI)	2018-04-03
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)	M.D. Anderson Cancer Center	2016-12-29
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery (NCT02734537)	ECOG-ACRIN Cancer Research Group	2016-11-23

Every clearance here is in the API, with alerts when new ones post.